 |
Chair:
Femida Gwadry-Sridhar PhD, RPh, MSc, BSc Phm, Assistant Professor, Departments of Medicine, Physiology and Pharmacology, University of Western Ontario; Assistant Professor, Department of Clinical Epidemiology and Biostatistics, McMaster University; Associate Director, Critical Care Research Network; Director of Health Informatics, Lawson Health Research Institute; CIHR New Investigator - Knowledge Translation |
Goal:
To stimulate research and evaluation on issues related to medication compliance, treatment persistence, and implications for health outcomes.
Background/Overview:
Compliance research requires an understanding about the best methodology to conduct studies especially when assessing interventions. Compliance studies include various designs such as: randomized controlled clinical trials, observational, and quasi- experimental studies. Key considerations for researchers regarding the design, analysis and reporting of results of such studies will be pursued within the scope of the work pursued by this SIG. |
| Working Groups: |
|
|
Accomplishments:
- Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature
- A framework for planning and critiquing medication compliance and persistence research using prospective study designs
Clinical Therapeutics, Volume 31, Issue 2, February 2009, Pages 421-435
Femida H. Gwadry-Sridhar, Elizabeth Manias, Ying Zhang, Anuja Roy, Kristina Yu-Isenberg, Dyfrig A. Hughes, Michael B. Nichol
- ISPOR Good Research Practices: A Checklist of Medication Compliance and Persistence Studies Using Retrospective Databases
- Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations
- Medication Compliance and Persistence: Terminology and Definitions
- Understanding Medication Compliance and Persistence from an Economics Perspective
- Bibliography of Medication Compliance and Persistence**
** please note currently not being updated
- Medication Compliance and Persistence: Terminology and Definitions
|
| Current Activities |
2010
- ISPOR Medication Compliance & Persistence SIG Forum Presented at the ISPOR 15th Annual International Meeting, Atlanta, GA, USA: May 2010
- Poster presentations at the ISPOR 15th Annual International Meeting, Atlanta, GA, USA: May 2010
PMS49: TRENDS IN THE PRESCRIBING OF CONVENTIONAL ANTIRHEUMATIC THERAPY AMONG CANADIANS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT STUDY
Gomez-Galicia DL1, Kezouh A2, Salas M3, Gwadry-Sridhar F4, Manias E5, Reyes-Esparza JA1, Hughes D6
1Universidad Autonoma del Estado de Morelos, Morelos, Mexico, 2McGill University Health Centre, Montréal, QC, Canada, 3University of Alabama at Birmingham, Birmingham, AL, USA, 4University of Western Ontario, London, ON, Canada, 5Melbourne School of Health Sciences, Carlton, Victoria, Australia, 6Bangor University, Bangor, United Kingdom
PCV100: INTERVENTIONS TO IMPROVE COMPLIANCE WITH LIPID LOWERING MEDICATIONS: A SYSTEMATIC REVIEW OF THE LITERATURE
Zuluaga A1, Salas M2, Gwadry-Sridhar F3, Manias E4, Hughes D5
1University of Alabama at Birmingham, Birmingham, AL, USA, 2AstraZeneca, LP, Wilmington, DE, USA, 3University of Western Ontario, Ontario, ON, Canada, 4Melbourne School of Health Sciences, Carlton, Victoria, Australia, 5Bangor University, Bangor, United Kingdom
Past Activities |
If you are interested in joining this ISPOR Special Interest Group, please complete the Special Interest Group
Application Form. |
|
Medication Compliance and Persistence SIG
Access for Leadership Group Members Only
 How to login
User name: first part of the email address (before @)
e.g. for jdoe@ispor.org it should be
jdoe)
Password: ISPOR Member ID.
Click here for login help |
